+关注
阿斯顿AA
暂无个人介绍
IP属地:云南
33
关注
2
粉丝
1
主题
0
勋章
主贴
热门
阿斯顿AA
2019-04-13
$Jumia Technologies AG(JMIA)$能不能回本就靠你了,到50没问题吧
阿斯顿AA
2019-04-23
$Greenlane Holdings Inc.(GNLN)$ 抽大麻合法化了,股价爆炸[财迷][财迷][财迷]
阿斯顿AA
2019-03-14
$优信(UXIN)$真牛逼
阿斯顿AA
2020-03-07
恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。
恩佐生化盘中异动 大幅上涨5.32%报2.46美元
阿斯顿AA
2019-04-23
$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]大妈大妈
阿斯顿AA
2019-04-23
$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]
阿斯顿AA
2019-03-13
$星光文化(01159)$疯狂吧
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3500451014333033","uuid":"3500451014333033","gmtCreate":1537356993822,"gmtModify":1706620600252,"name":"阿斯顿AA","pinyin":"esdaaesidunaa","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":33,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"云南","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":981379375,"gmtCreate":1583519548897,"gmtModify":1704350212317,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。","listText":"恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。","text":"恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/981379375","repostId":"2010202240","repostType":2,"repost":{"id":"2010202240","kind":"news","pubTimestamp":1581431555,"share":"https://www.laohu8.com/m/news/2010202240?lang=&edition=full","pubTime":"2020-02-11 22:32","market":"us","language":"zh","title":"恩佐生化盘中异动 大幅上涨5.32%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2010202240","media":"自选股智能写手","summary":"北京时间2020年02月11日22时32分,恩佐生化(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。最近的财","content":"<html><body><article><p>北京时间2020年02月11日22时32分,<a href=\"https://laohu8.com/S/ENZ\">恩佐生化</a>(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。</p><p>最近的财报数据显示,该股实现营业收入20.21百万美元,净利润-7.65百万美元,每股收益-0.16美元,毛利5.69百万美元,市盈率123.22倍。</p><p>机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。</p><p>恩佐生化股票所在的生命科学行业中,整体涨幅为0.65%。其相关个股中,Interpace Biosciences Inc、Fluidigm Corp、<a href=\"https://laohu8.com/S/CRL\">查尔斯河</a>实验室涨幅较大,Co-Diagnostics Inc、Interpace Biosciences Inc、<a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a> Inc较为活跃,换手率分别为15.15%、2.23%、0.50%,振幅较大的相关个股有Interpace Biosciences Inc、Syneos Health Inc、Fluidigm Corp,振幅分别为12.13%、3.95%、3.77%。</p><p>恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。</p><p>(以上内容为自选股智能机器写手Money Call完成,仅作为用户看盘参考,不作为交易依据。)</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恩佐生化盘中异动 大幅上涨5.32%报2.46美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恩佐生化盘中异动 大幅上涨5.32%报2.46美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-02-11 22:32 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021122323579a896a6&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2020年02月11日22时32分,恩佐生化(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。最近的财报数据显示,该股实现营业收入20.21百万美元,净利润-7.65百万美元,每股收益-0.16美元,毛利5.69百万美元,市盈率123.22倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021122323579a896a6&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/edc98c04cdc47dd0d16e08274ce9a364","relate_stocks":{"ENZ":"恩佐生化"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021122323579a896a6&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2010202240","content_text":"北京时间2020年02月11日22时32分,恩佐生化(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。最近的财报数据显示,该股实现营业收入20.21百万美元,净利润-7.65百万美元,每股收益-0.16美元,毛利5.69百万美元,市盈率123.22倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。恩佐生化股票所在的生命科学行业中,整体涨幅为0.65%。其相关个股中,Interpace Biosciences Inc、Fluidigm Corp、查尔斯河实验室涨幅较大,Co-Diagnostics Inc、Interpace Biosciences Inc、Bionano Genomics Inc较为活跃,换手率分别为15.15%、2.23%、0.50%,振幅较大的相关个股有Interpace Biosciences Inc、Syneos Health Inc、Fluidigm Corp,振幅分别为12.13%、3.95%、3.77%。恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。(以上内容为自选股智能机器写手Money Call完成,仅作为用户看盘参考,不作为交易依据。)","news_type":1},"isVote":1,"tweetType":1,"viewCount":945,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909010133,"gmtCreate":1556013007022,"gmtModify":1704799763170,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]大妈大妈","listText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]大妈大妈","text":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]大妈大妈","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/909010133","isVote":1,"tweetType":1,"viewCount":856,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909010316,"gmtCreate":1556012971935,"gmtModify":1704799763343,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Greenlane Holdings Inc.(GNLN)$ 抽大麻合法化了,股价爆炸[财迷][财迷][财迷]","listText":"$Greenlane Holdings Inc.(GNLN)$ 抽大麻合法化了,股价爆炸[财迷][财迷][财迷]","text":"$Greenlane Holdings Inc.(GNLN)$ 抽大麻合法化了,股价爆炸[财迷][财迷][财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/909010316","isVote":1,"tweetType":1,"viewCount":2781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909095601,"gmtCreate":1556005806603,"gmtModify":1704799746013,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]","listText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]","text":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/909095601","isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":468343,"gmtCreate":1555113962320,"gmtModify":1704798093082,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Jumia Technologies AG(JMIA)$能不能回本就靠你了,到50没问题吧","listText":"$Jumia Technologies AG(JMIA)$能不能回本就靠你了,到50没问题吧","text":"$Jumia Technologies AG(JMIA)$能不能回本就靠你了,到50没问题吧","images":[{"img":"https://static.tigerbbs.com/9ed34aee8b2cdb0d2066486288e6de58"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/468343","isVote":1,"tweetType":1,"viewCount":7876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":428223,"gmtCreate":1552571165349,"gmtModify":1704792913189,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$优信(UXIN)$真牛逼","listText":"$优信(UXIN)$真牛逼","text":"$优信(UXIN)$真牛逼","images":[{"img":"https://static.tigerbbs.com/9cdf90db10e14c247e822c4f9adea1ff"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/428223","isVote":1,"tweetType":1,"viewCount":1700,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":425579,"gmtCreate":1552459419003,"gmtModify":1704792569428,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$星光文化(01159)$疯狂吧","listText":"$星光文化(01159)$疯狂吧","text":"$星光文化(01159)$疯狂吧","images":[{"img":"https://static.tigerbbs.com/42863c08212a027ed858189473058458"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425579","isVote":1,"tweetType":1,"viewCount":1702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":468343,"gmtCreate":1555113962320,"gmtModify":1704798093082,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Jumia Technologies AG(JMIA)$能不能回本就靠你了,到50没问题吧","listText":"$Jumia Technologies AG(JMIA)$能不能回本就靠你了,到50没问题吧","text":"$Jumia Technologies AG(JMIA)$能不能回本就靠你了,到50没问题吧","images":[{"img":"https://static.tigerbbs.com/9ed34aee8b2cdb0d2066486288e6de58"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/468343","isVote":1,"tweetType":1,"viewCount":7876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":909010316,"gmtCreate":1556012971935,"gmtModify":1704799763343,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Greenlane Holdings Inc.(GNLN)$ 抽大麻合法化了,股价爆炸[财迷][财迷][财迷]","listText":"$Greenlane Holdings Inc.(GNLN)$ 抽大麻合法化了,股价爆炸[财迷][财迷][财迷]","text":"$Greenlane Holdings Inc.(GNLN)$ 抽大麻合法化了,股价爆炸[财迷][财迷][财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/909010316","isVote":1,"tweetType":1,"viewCount":2781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":428223,"gmtCreate":1552571165349,"gmtModify":1704792913189,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$优信(UXIN)$真牛逼","listText":"$优信(UXIN)$真牛逼","text":"$优信(UXIN)$真牛逼","images":[{"img":"https://static.tigerbbs.com/9cdf90db10e14c247e822c4f9adea1ff"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/428223","isVote":1,"tweetType":1,"viewCount":1700,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":981379375,"gmtCreate":1583519548897,"gmtModify":1704350212317,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。","listText":"恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。","text":"恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/981379375","repostId":"2010202240","repostType":2,"repost":{"id":"2010202240","kind":"news","pubTimestamp":1581431555,"share":"https://www.laohu8.com/m/news/2010202240?lang=&edition=full","pubTime":"2020-02-11 22:32","market":"us","language":"zh","title":"恩佐生化盘中异动 大幅上涨5.32%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2010202240","media":"自选股智能写手","summary":"北京时间2020年02月11日22时32分,恩佐生化(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。最近的财","content":"<html><body><article><p>北京时间2020年02月11日22时32分,<a href=\"https://laohu8.com/S/ENZ\">恩佐生化</a>(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。</p><p>最近的财报数据显示,该股实现营业收入20.21百万美元,净利润-7.65百万美元,每股收益-0.16美元,毛利5.69百万美元,市盈率123.22倍。</p><p>机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。</p><p>恩佐生化股票所在的生命科学行业中,整体涨幅为0.65%。其相关个股中,Interpace Biosciences Inc、Fluidigm Corp、<a href=\"https://laohu8.com/S/CRL\">查尔斯河</a>实验室涨幅较大,Co-Diagnostics Inc、Interpace Biosciences Inc、<a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a> Inc较为活跃,换手率分别为15.15%、2.23%、0.50%,振幅较大的相关个股有Interpace Biosciences Inc、Syneos Health Inc、Fluidigm Corp,振幅分别为12.13%、3.95%、3.77%。</p><p>恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。</p><p>(以上内容为自选股智能机器写手Money Call完成,仅作为用户看盘参考,不作为交易依据。)</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恩佐生化盘中异动 大幅上涨5.32%报2.46美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恩佐生化盘中异动 大幅上涨5.32%报2.46美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-02-11 22:32 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021122323579a896a6&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2020年02月11日22时32分,恩佐生化(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。最近的财报数据显示,该股实现营业收入20.21百万美元,净利润-7.65百万美元,每股收益-0.16美元,毛利5.69百万美元,市盈率123.22倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021122323579a896a6&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/edc98c04cdc47dd0d16e08274ce9a364","relate_stocks":{"ENZ":"恩佐生化"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020021122323579a896a6&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2010202240","content_text":"北京时间2020年02月11日22时32分,恩佐生化(ENZ.us)股票出现波动,股价急速上涨5.32%。截至发稿,该股报2.46美元/股,成交量5293股,换手率0.01%,振幅3.42%。最近的财报数据显示,该股实现营业收入20.21百万美元,净利润-7.65百万美元,每股收益-0.16美元,毛利5.69百万美元,市盈率123.22倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。恩佐生化股票所在的生命科学行业中,整体涨幅为0.65%。其相关个股中,Interpace Biosciences Inc、Fluidigm Corp、查尔斯河实验室涨幅较大,Co-Diagnostics Inc、Interpace Biosciences Inc、Bionano Genomics Inc较为活跃,换手率分别为15.15%、2.23%、0.50%,振幅较大的相关个股有Interpace Biosciences Inc、Syneos Health Inc、Fluidigm Corp,振幅分别为12.13%、3.95%、3.77%。恩佐生化公司简介:Enzo Biochem Inc是一家生物科学公司。该公司生产、开发并向国际上的临床实验室、专科诊所、研究人员和医师销售其专有的解决方案和平台。它专注于交付和应用其技术来生产产品和服务,以使客户能够满足他们的临床需要。公司拥有恩佐临床实验室、恩佐生命科学、恩佐治疗学等业务板块。它的大部分收入来自临床实验室部门。(以上内容为自选股智能机器写手Money Call完成,仅作为用户看盘参考,不作为交易依据。)","news_type":1},"isVote":1,"tweetType":1,"viewCount":945,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909010133,"gmtCreate":1556013007022,"gmtModify":1704799763170,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]大妈大妈","listText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]大妈大妈","text":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]大妈大妈","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/909010133","isVote":1,"tweetType":1,"viewCount":856,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":909095601,"gmtCreate":1556005806603,"gmtModify":1704799746013,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]","listText":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]","text":"$Greenlane Holdings Inc.(GNLN)$ [愤怒][愤怒][愤怒][愤怒][愤怒]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/909095601","isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":425579,"gmtCreate":1552459419003,"gmtModify":1704792569428,"author":{"id":"3500451014333033","authorId":"3500451014333033","name":"阿斯顿AA","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3500451014333033","idStr":"3500451014333033"},"themes":[],"htmlText":"$星光文化(01159)$疯狂吧","listText":"$星光文化(01159)$疯狂吧","text":"$星光文化(01159)$疯狂吧","images":[{"img":"https://static.tigerbbs.com/42863c08212a027ed858189473058458"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425579","isVote":1,"tweetType":1,"viewCount":1702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}